Skip to main content
Equibles
CLB logo

CLB · Core Laboratories Inc. /DE/ · Webcasts, Transcripts & Audio

Track CLB — free

Use CLB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.55 +0.63 (+6.30%)
Russell 2000 member Rebalance outlook locked
Market Cap
$448.75M
Shares
45.88M
Volume · Oct 5 490.68K Avg daily vol (3M) 640.39K

Core Laboratories Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Core Laboratories Inc. (CLB), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $125.97M $7.52M '22 Q3 22-09-30 · $128.36M $2.37M '23 Q1 23-03-31 ▲5.8% $127.88M $22.85M '23 Q2 23-07-26 ▼0.5% $125.34M $9.26M '23 Q3 23-11-01 · $128.21M $2.20M '23 Q4 24-01-31 ▲1% $129.64M $3.22M '24 Q1 24-04-24 ▲2.1% $130.58M $9.03M '24 Q2 24-07-24 ▲7.2% $134.40M $11.74M '24 Q3 24-10-23 ▲0.8% $129.24M $7.40M '24 Q4 25-01-29 ▼4.7% $123.58M −$154,000 '25 Q1 25-04-23 ▼0.3% $130.16M $10.64M '25 Q2 25-07-23 ▲0.1% $134.52M $14.24M '25 Q3 25-10-22 ▲7% $138.25M $4.95M '25 Q4 26-02-05 ▼1.4% $121.80M −$789,000 '26 Q1 26-04-30 LATEST ▼4.3% $124.61M $5.96M '26 Q2 26-07-30
Earnings call
FY26 · Q2
2026-07-30
Core Laboratories Inc. (CLB) Q2 2026 Earnings Call
Revenue
$124.61M
▼ 4.3% YoY
Diluted EPS
$0.13
▼ 40.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-30
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Cautious tone Reservoir Description segment Production Enhancement segment Shareholder returns and capital allocation
Revenue
$121.80M
▼ 1.4% YoY
Diluted EPS
$-0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-05
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Positive tone International demand and Reservoir Description growth Production Enhancement performance and APAC receivable Capital returns and shareholder value
Revenue
$138.25M*
▲ 7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-22
Core Laboratories Inc. (CLB) Q3 2025 Earnings Call Transcript
Positive tone Sequential revenue and margin improvement Capital return and shareholder value Reservoir Description segment performance
Revenue
$134.52M
▲ 0.1% YoY
Diluted EPS
$0.30
▲ 20% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-23
Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript
Positive tone Sequential revenue and margin improvement Production Enhancement segment Reservoir Description segment
Revenue
$130.16M
▼ 0.3% YoY
Diluted EPS
$0.22
▲ 15.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Core Laboratories Inc. (CLB) Q1 2025 Earnings Call Transcript
Balanced tone Geopolitical conflicts and sanctions impact Production Enhancement segment International growth opportunities
Revenue
$123.58M
▼ 4.7% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-29
Core Laboratories Inc. (CLB) Q4 2024 Earnings Call Transcript
Positive tone Reservoir Description segment performance Technology and innovation strategy Balance sheet and deleveraging
Revenue
$129.24M*
▲ 0.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-23
Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript
Balanced tone Revenue growth and sequential improvement Free cash flow and shareholder returns Reservoir Description and international services
Revenue
$134.40M
▲ 7.2% YoY
Diluted EPS
$0.25
▲ 31.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Core Laboratories Inc. (CLB) Q2 2024 Earnings Call Transcript
Positive tone Debt Reduction and Balance Sheet Sequential Financial Improvement Production Enhancement Segment
Revenue
$130.58M
▲ 2.1% YoY
Diluted EPS
$0.19
▼ 60.4% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript
Positive tone Sequential revenue and margins Geopolitical disruption to crude oil flows Production Enhancement segment
Revenue
$129.64M
▲ 1% YoY
Diluted EPS
$0.07
▲ 40% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-31
Core Laboratories Inc. (CLB) Q4 2023 Earnings Call Transcript
Positive tone Operational momentum and reservoir description demand International and Middle East project activity Production Enhancement segment
Revenue
$128.21M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Core Laboratories Inc. (CLB) Q3 2023 Earnings Call Transcript
Revenue
$125.34M
▼ 0.5% YoY
Diluted EPS
$0.19
▲ 18.8% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Core Laboratories Inc. (CLB) Q2 2023 Earnings Call Transcript
Revenue
$127.88M
▲ 5.8% YoY
Diluted EPS
$0.48
▲ 220% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Core Laboratories Inc. (CLB) Q1 2023 Earnings Call Transcript
Revenue
$128.36M
Diluted EPS
$0.05
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Core Laboratories Inc. (CLB) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Core Laboratories Inc. (CLB) Q3 2022 Earnings Call Transcript
Revenue
$125.97M
Diluted EPS
$0.16
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Core Laboratories Inc. (CLB) Q2 2022 Earnings Call Transcript
Revenue
$120.90M
Diluted EPS
$0.15
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Core Laboratories Inc. (CLB) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Core Laboratories Inc. (CLB) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Core Laboratories Inc. (CLB) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Core Laboratories Inc. (CLB) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Core Laboratories Inc. (CLB) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Core Laboratories Inc. (CLB) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Core Laboratories Inc. (CLB) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Core Laboratories Inc. (CLB) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Core Laboratories Inc. (CLB) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 webcasts
Key facts CIK 1958086 CUSIP 21867A105 13F (30d) 6 filings 6 filers Visit website Investor relations